17
Participants
Start Date
October 31, 2014
Primary Completion Date
April 30, 2016
Study Completion Date
July 31, 2016
Mocetinostat
Memorial Sloan Kettering Cancer Center, New York
University of Rochester, Rochester
Johns Hopkins University, Baltimore
University of North Carolina, Chapel Hill
Florida Cancer Specialists, Fort Myers
University of Alabama, Birmingham
Ohio State University, Columbus
Cleveland Clinic Foundation, Cleveland
University of Michigan, Ann Arbor
University of Chicago, Chicago
Washington University, St Louis
Huntsman Cancer Institute, Salt Lake City
City of Hope National Medical Center, Duarte
Dana-Farber Cancer Institute, Boston
Lead Sponsor
Mirati Therapeutics Inc.
INDUSTRY